University of Maryland, Baltimore
Baltimore, Maryland, 21210, United States
NCT Number: NCT07536412
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21210, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Decision aid developed by Pitt & Saucke (2020) called CQUPLE (chart & question prompt list)
Time frame: (1) Baseline, (2) after receiving decision aid (approx Day 1 to Day 30), and (3) after going to surgeon clinic appointment (approx Day 2 to Day 45)
Decisional conflict will be quantified with the Decisional Conflict Scale (DCS). Range: 0 [no decisional conflict] to 100 [extremely high decisional conflict]
Time frame: (1) Baseline, (2) after receiving decision aid (approx Day 1 to Day 30), and (3) after going to surgeon clinic appointment (approx Day 2 to Day 45)
Anxiety about decision-making will be measured using Spielberger's State Trait Anxiety Index (STAI) 6-item state form. Range: 4.09 [highly anxious] to -4.14 [not at all anxious].
Time frame: (1) Baseline, (2) after receiving decision aid (approx Day 1 to Day 30), and (3) after going to surgeon clinic appointment (approx Day 2 to Day 45)
Decision readiness will be measured with the Stage of Decision-making (Stage-DM) scale. Range: 1 ["haven't begun to think about the choices"] to 6 ["have already made a decision and am unlikely to change my mind"].
Time frame: After receiving decision aid (approx Day 1 to Day 30)
Decision aid acceptability will be measured with the Preparation for Decision-Making (Prep-DM) scale. Range: 0 [lowest level of preparation for decision-making] to 100 [highest level of preparation for decision-making].
Contact information is provided by the study sponsor or research team.
University of Maryland, Baltimore
Other
Efficacy of a Patient-facing Decision Aid in Reducing Decision Anxiety and Improving Decision Readiness in Low Risk Thyroid Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01788982
Adenocarcinoma, Carcinoma
Bruges, Belgium
View Trial DetailsNCT07620574
Adenocarcinoma, Cancer
View Trial DetailsNCT04940052
Differentiated Thyroid Cancer (DTC)
Chicago, Illinois, United States
View Trial DetailsNCT07229859
Differentiated Thyroid Cancer (DTC), Robotic Assistance
Shanghai, Shanghai Municipality, China
View Trial Details